Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (29)
Vanessa Steindorf, Sergio Oliva, Nico Stollenwerk & Maíra Aguiar. (2024) Symmetry in a multi-strain epidemiological model with distributed delay as a general cross-protection period and disease enhancement factor. Communications in Nonlinear Science and Numerical Simulation 128, pages 107663.
Crossref
Crossref
Maíra Aguiar, Vizda Anam, Konstantin B. Blyuss, Carlo Delfin S. Estadilla, Bruno V. Guerrero, Damián Knopoff, Bob W. Kooi, Luís Mateus, Akhil Kumar Srivastav, Vanessa Steindorf & Nico Stollenwerk. (2023) Prescriptive, descriptive or predictive models: What approach should be taken when empirical data is limited? Reply to comments on “Mathematical models for Dengue fever epidemiology: A 10-year systematic review”. Physics of Life Reviews 46, pages 56-64.
Crossref
Crossref
Akhil Kumar Srivastav, Vanessa Steindorf, Nico Stollenwerk & Maíra Aguiar. (2023) The effects of public health measures on severe dengue cases: An optimal control approach. Chaos, Solitons & Fractals 172, pages 113577.
Crossref
Crossref
Nico Stollenwerk, Carlo Delfin S. Estadilla, Javier Mar, Joseba Bidaurrazaga Van-Dierdonck, Oliver Ibarrondo, Rubén Blasco-Aguado & Maíra Aguiar. (2023) The effect of mixed vaccination rollout strategy: A modelling study. Infectious Disease Modelling 8:2, pages 318-340.
Crossref
Crossref
Scott B. Halstead. 2023. History of Arbovirology: Memories from the Field. History of Arbovirology: Memories from the Field
227
313
.
Akhil Kumar Srivasrav, Nico Stollenwerk, Joseba Bidaurrazaga Van-Dierdonck, Javier Mar, Oliver Ibarrondo & Maíra Aguiar. (2022) Modeling the initial phase of COVID-19 epidemic: The role of age and disease severity in the Basque Country, Spain. PLOS ONE 17:7, pages e0267772.
Crossref
Crossref
Akhil Kumar Srivastav, Nico Stollenwerk & Maíra Aguiar. (2022) Deterministic and Stochastic Dynamics of COVID-19: The Case Study of Italy and Spain. Computational and Mathematical Methods 2022, pages 1-16.
Crossref
Crossref
Vanessa Steindorf, Sergio Oliva, Jianhong Wu & Maíra Aguiar. (2022) Effect of General Cross-Immunity Protection and Antibody-Dependent Enhancement in Dengue Dynamics. Computational and Mathematical Methods 2022, pages 1-22.
Crossref
Crossref
Heidi Auerswald, Simone Kann, Leonard Klepsch, Janne Hülsemann, Ines Rudnik, Sebastian Schreiber, Philippe Buchy & Michael Schreiber. (2021) Neutralization of Dengue Virus Serotypes by Sera from Dengue-Infected Individuals Is Preferentially Directed to Heterologous Serotypes and Not against the Autologous Serotype Present in Acute Infection. Viruses 13:10, pages 1957.
Crossref
Crossref
Afrina Andriani Sebayang, Hilda Fahlena, Vizda Anam, Damián Knopoff, Nico Stollenwerk, Maíra Aguiar & Edy Soewono. (2021) Modeling Dengue Immune Responses Mediated by Antibodies: A Qualitative Study. Biology 10:9, pages 941.
Crossref
Crossref
Ken-ichiro Matsunaga, Michiko Kimoto, Vanessa Weixun Lim, Tun-Linn Thein, Shawn Vasoo, Yee-Sin Leo, William Sun & Ichiro Hirao. (2021) Competitive ELISA for a serologic test to detect dengue serotype-specific anti-NS1 IgGs using high-affinity UB-DNA aptamers. Scientific Reports 11:1.
Crossref
Crossref
Euzebiusz Jamrozik, George Heriot, Susan Bull & Michael Parker. (2021) Vaccine-enhanced disease: case studies and ethical implications for research and public health. Wellcome Open Research 6, pages 154.
Crossref
Crossref
Baptiste Vasey, Anuraj H. Shankar, Bobby Brooke Herrera, Aniuska Becerra, Kris Xhaja, Marion Echenagucia, Sara R. Machado, Diana Caicedo, John Miller, Paolo Amedeo, Elena N. Naumova & Irene Bosch. (2020) Multivariate time-series analysis of biomarkers from a dengue cohort offers new approaches for diagnosis and prognosis. PLOS Neglected Tropical Diseases 14:6, pages e0008199.
Crossref
Crossref
Jean A. Bernatchez, Lana T. Tran, Jerry Li, Yepeng Luan, Jair L. Siqueira-Neto & Rongshi Li. (2019) Drugs for the Treatment of Zika Virus Infection. Journal of Medicinal Chemistry 63:2, pages 470-489.
Crossref
Crossref
Nipa Thammasonthijarern, Wilarat Puangmanee, Pimolpachr Sriburin, Subenya Injampa, Supawat Chatchen, Weerapong Phumirattanaprapin, Chonlatip Pipattanaboon, Pongrama Ramasoota & Pannamthip Pitaksajjakul. (2020) Human Heavy Chain Antibody Genes Elicited in Thai Dengue Patients during DENV2 Secondary Infection. Japanese Journal of Infectious Diseases 73:2, pages 140-147.
Crossref
Crossref
Patrícia Mouta Nunes de Oliveira, Letícia Kegele Lignani, Deborah Araújo da Conceição, Paula Molinari Cardoso de Mello Farias, Paulo Roberto Gomes Takey, Maria de Lourdes de Sousa Maia & Luiz Antonio Bastos Camacho. (2020) O panorama da vigilância de eventos adversos pós-vacinação ao fim da década de 2010: importância, ferramentas e desafios. Cadernos de Saúde Pública 36:suppl 2.
Crossref
Crossref
Joel Aik, Zhi Wei Neo, Jayanthi Rajarethinam, Kaiyun Chio, Wing Mun Lam & Lee-Ching Ng. (2019) The effectiveness of inspections on reported mosquito larval habitats in households: A case-control study. PLOS Neglected Tropical Diseases 13:6, pages e0007492.
Crossref
Crossref
Thomas Langerak, Noreen Mumtaz, Vera I. Tolk, Eric C. M. van Gorp, Byron E. Martina, Barry Rockx & Marion P. G. Koopmans. (2019) The possible role of cross-reactive dengue virus antibodies in Zika virus pathogenesis. PLOS Pathogens 15:4, pages e1007640.
Crossref
Crossref
Stephan T Kudlacek & Stefan W Metz. (2019) Focused dengue vaccine development: outwitting nature's design. Pathogens and Disease 77:1.
Crossref
Crossref
Jhon Carlos Castaño-Osorio, Alejandra María Giraldo-Garcia & Maria Isabel Giraldo. 2019. Dengue Fever - a Resilient Threat in the Face of Innovation. Dengue Fever - a Resilient Threat in the Face of Innovation.
Stefan W. Metz, Ashlie Thomas, Alex Brackbill, Yi Xianwen, Michele Stone, Katie Horvath, Michael J. Miley, Chris Luft, Joseph M. DeSimone, Shaomin Tian & Aravinda M. de Silva. (2018) Nanoparticle delivery of a tetravalent E protein subunit vaccine induces balanced, type-specific neutralizing antibodies to each dengue virus serotype. PLOS Neglected Tropical Diseases 12:9, pages e0006793.
Crossref
Crossref
Hugo C Turner, Bridget A Wills, Motiur Rahman, Hoang Quoc Cuong, Guy E Thwaites, Maciej F Boni & Hannah E Clapham. (2018) Projected costs associated with school-based screening to inform deployment of Dengvaxia: Vietnam as a case study. Transactions of The Royal Society of Tropical Medicine and Hygiene 112:8, pages 369-377.
Crossref
Crossref
Minhua Peng, Crystall Marie Dawn Swarbrick, Kitti Wing-Ki Chan, Dahai Luo, Wei Zhang, Xiaoping Lai, Geng Li & Subhash G. Vasudevan. (2018) Luteolin escape mutants of dengue virus map to prM and NS2B and reveal viral plasticity during maturation. Antiviral Research 154, pages 87-96.
Crossref
Crossref
Adam M. Finkel, Benjamin D. Trump, Diana Bowman & Andrew Maynard. (2018) A “solution-focused” comparative risk assessment of conventional and synthetic biology approaches to control mosquitoes carrying the dengue fever virus. Environment Systems and Decisions 38:2, pages 177-197.
Crossref
Crossref
Maíra Aguiar. (2018) Dengue vaccination: a more ethical approach is needed. The Lancet 391:10132, pages 1769-1770.
Crossref
Crossref
Maíra Aguiar & Nico Stollenwerk. (2018) Dengvaxia: age as surrogate for serostatus. The Lancet Infectious Diseases 18:3, pages 245.
Crossref
Crossref
Maíra Aguiar & Nico Stollenwerk. (2018) Dengvaxia Efficacy Dependency on Serostatus: A Closer Look at More Recent Data. Clinical Infectious Diseases 66:4, pages 641-642.
Crossref
Crossref
Aaron L. Oom, Davey Smith & Kevan Akrami. (2017) Identification of putative unique immunogenic ZIKV and DENV1-4 peptides for diagnostic cellular based tests. Scientific Reports 7:1.
Crossref
Crossref
Miao Wang, Fan Yang, Dana Huang, Yalan Huang, Xiaomin Zhang, Chao Wang, Shaohua Zhang & Renli Zhang. (2017) Anti-Idiotypic Antibodies Specific to prM Monoantibody Prevent Antibody Dependent Enhancement of Dengue Virus Infection. Frontiers in Cellular and Infection Microbiology 7.
Crossref
Crossref